Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

Answer questions and earn CME/CNE Comorbidity is common among cancer patients and,
with an aging population, is becoming more so. Comorbidity potentially affects the …

The present report focuses on the various aspects of oral delivery of anticancer drugs. The
significance of oral delivery in cancer therapeutics has been highlighted which principally …

Objective: Drug–drug interactions (DDIs) can cause failure in treatment and adverse events.
DDIs screening software is an important tool to aid clinicians in the detection and …

Purpose Several electronic databases which report the prevalence of drug-drug interactions
(DDIs) are used as a tool for evaluation of potentially harmful DDIs. The aim of our review …

PURPOSE Oral anticancer drugs (eg, kinase inhibitors) play an important role in cancer
therapy. However, considerable challenges regarding medication safety of oral anticancer …

Proteasome inhibitors disrupt multiple pathways in cells and the bone marrow
microenvironment, resulting in apoptosis and inhibition of cell-cycle progression …

Drug interactions are of major concern, since cancer patients take many medications and
may have serious consequences. Therefore, a study was designed to identify interactions …

Background Cancer patients often receive multiple drugs to maximize their therapeutic
benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant …

Recently, photodynamic therapy (PDT) has received a lot of attention for its potential use in
cancer treatment. It enables the therapy of a multifocal disease with the least amount of …